MARKET

TLGT

TLGT

Teligent Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2977
+0.0234
+8.53%
After Hours: 0.3076 +0.0099 +3.33% 16:42 03/27 EDT
OPEN
0.2736
PREV CLOSE
0.2743
HIGH
0.3036
LOW
0.2736
VOLUME
95.43K
TURNOVER
--
52 WEEK HIGH
1.300
52 WEEK LOW
0.1900
MARKET CAP
16.03M
P/E (TTM)
-0.4682
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TLGT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TLGT stock price target is 5.00 with a high estimate of 5.00 and a low estimate of 5.00.

EPS

TLGT News

More
  • The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
  • Benzinga · 03/13 11:52
  • Did Changing Sentiment Drive Teligent's (NASDAQ:TLGT) Share Price Down A Disastrous 96%?
  • Simply Wall St. · 02/06 19:33
  • South Jersey specialty generic drug manufacturer names new CEO
  • American City Business Journals · 02/05 18:56
  • Teligent Has Announced That Jason Grenfell-Gardner Will Be Stepping Down Immediately As President, CEO And Member Of The Board Of Director
  • Benzinga · 02/05 13:23

Industry

Pharmaceuticals
-0.41%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About TLGT

Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.
More

Webull offers kinds of Teligent Inc (NEW JERSEY) stock information, including NASDAQ:TLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLGT stock news, and many more online research tools to help you make informed decisions.